Interventional Cardiology :: Nationwide Children's Hospital

Featured Physician: Dr. John Cheatham

“Our specialized Hybrid Cardiac Suites really are the embodiment of what we are trying to accomplish at the Heart Center. Our patients will have less scarring, less pain, fewer complications and an improved overall quality of life.”

- John P. Cheatham, MD, FAAP, FACC, FSCAI, Director of Cardiac Catheterization and Interventional Therapy

Make a Referral

Do you have a child or patient who needs to be seen at Nationwide Children's Hospital?
 

Interventional Cardiology

Interventional cardiology is truly the future of heart care for children and adults, allowing complex procedures to be successfully completed while leaving the patient with a band-aid, rather than a scar. At Nationwide Children's Heart Center, the full range of interventional cardiology procedures is available:

  • Balloon dilation of stenotic valves or narrowed vessels

  • Catheterization

  • Coil embolization of undesirable vessels and patent ductus

  • Radiofrequency and Cryogenic catheter ablation of accessory conduction pathways

  • Stenting of narrowed vessels

Dramatic improvements in interventional cardiac catheterization treatments and techniques allow specialists to care for more and more cardiac problems without surgery. Our cardiac interventionists are among the best in the world, pioneering treatments right here at Nationwide Children's Heart Center. This innovative spirit has led to a collaborative interventional catheterization and cardiothoracic surgery program, causing the lines between transcatheter and surgical treatment strategies to blur. Thus, the Heart Center’s need for a therapeutic suite that is compatible with both interventional cardiology and cardiothoracic surgery – learn more about our one-of-a-kind Hybrid Cardiac Suites.

To learn more about Interventional Cardiology at Nationwide Children's Heart Center, watch our video.
high bandwith video | low bandwith video

The Heart Center had a key role in the FDA approval of the Medtronic Melody Transcatheter Pulmonary Valve and Ensemble Delivery System as well as with the development of both the stent and balloon-in-balloon products. This new treatment is the first in the United States offering minimally-invasive treatment options for congenital heart disease patients. This will help minimize and delay the need for multiple open heart surgeries over a patient's lifetime. Nationwide Children's was one of five initial clinical trial locations.

Nationwide Children's Stent Development Lays Groundwork for Melody Valve

The Heart Center had a key role in the FDA approval of the Medtronic Melody Transcatheter Pulmonary Valve and Ensemble Delivery System as well as with the development of both the stent and balloon-in-balloon products. This new treatment is the first in the United States offering minimally-invasive treatment options for congenital heart disease patients. This will help minimize and delay the need for multiple open heart surgeries over a patient's lifetime. Nationwide Children's was one of five initial clinical trial locations.

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000